33.
23.
According to a new Yale-led study, the physical stress of running a marathon can cause short-term kidney injury. Although kidneys of the examined runners fully recovered within two days post-marathon, the study raises questions concerning potential long-term impacts of this strenuous activity at a time when marathons are increasing in popularity.
The study was published March 28 by the American Journal of Kidney Diseases.
Five simple medical tests together provide a broader and more accurate assessment of heart-disease risk than currently used methods, cardiologists at UT Southwestern Medical Center found.
Combined, results from the five tests -- an EKG, a limited CT scan, and three blood tests -- better predict who will develop heart disease compared with standard strategies that focus on blood pressure, cholesterol, diabetes, and smoking history, researchers reported.
Newswise — JUPITER, FL – March 27, 2017 – Scientists may have found a new tool for studying—and maybe even treating—Type 2 diabetes, the form of diabetes considered responsible for close to 95 percent of cases in the United States.
A team of scientists from the Florida campus of The Scripps Research Institute (TSRI), Dana-Farber Cancer Institute, Harvard Medical School and the Yale University School of Medicine, among others, have identified a new class of compounds that reduce production of glucose in the liver. One of these compounds, designed and optimized by TSRI scientists, significantly improves the health of diabetic animal models by reducing glucose levels in the blood, increasing insulin sensitivity and improving glucose balance.
David Hay Jones/Science Photo Library
%PDF-1.5 %âãÏÓ 100 0 obj > endobj 123 0 obj >/Filter/FlateDecode/ID[]/Index[100 45]/Info 99 0 R/Length 102/Prev 124221/Root 101 0 R/Size 145/Type/XRef/W[1 2 1]>>stream hÞbbd``b`z$XKëWk.`v"ôA XҦ$¸¢w4`
All European Union Member States have made commitments towards reducing inequalities in access to health care and in health outcomes. But substantial differences in mortality rates persist in the paediatric renal replacement therapy population across Europe. This is the sad result of a brand new study published in The Lancet this week.
The authors extracted and carefully analyzed patient data from the European Society for Paediatric Nephrology/European Renal Association-European Dialysis and Transplant Association (ESPN/ERA-EDTA) Registry for 32 European countries. In summary, the analysis showed that public health expenditure was inversely associated with mortality risk and explained 67% of the variation in renal replacement therapy mortality rates between countries. Moreover, differences between countries in their ability to treat the youngest patients, who are typically the most complex and costly to treat, were an important driver for poor outcomes.
The research describes how the peptide stops levels of a protein called FOXO4 from increasing in senescent cells, which are cells that lose the ability to replicate and destroy themselves, but which remain metabolically active.
Senescent cells accumulate with age, and studies have shown that they can contribute to the aging process by causing damage to neighboring cells and impairing tissue function.
A protein in spider venom may help protect the brain from injury after a stroke, according to research.
Scientists found a single dose of the protein Hi1a worked on lab rats.
As you were browsing http://www.mdlinx.com something about your browser made us think you were a bot. There are a few reasons this might happen:
You're a power user moving through this website with super-human speed. You've disabled JavaScript in your web browser. A third-party browser plugin, such as Ghostery or NoScript, is preventing JavaScript from running. Additional information is available in this support article.To request an unblock, please fill out the form below and we will review it as soon as possible.
As you were browsing http://www.mdlinx.com something about your browser made us think you were a bot. There are a few reasons this might happen:
You're a power user moving through this website with super-human speed. You've disabled JavaScript in your web browser. A third-party browser plugin, such as Ghostery or NoScript, is preventing JavaScript from running. Additional information is available in this support article.To request an unblock, please fill out the form below and we will review it as soon as possible.
